Correction to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
Crossref DOI link: https://doi.org/10.1007/s10637-019-00763-x
Published Online: 2019-04-24
Published Print: 2019-08-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weiss, Glen J.
Blaydorn, Lisa
Beck, Julia
Bornemann-Kolatzki, Kirsten
Urnovitz, Howard
Schütz, Ekkhard
Khemka, Vivek
Text and Data Mining valid from 2019-04-24
Version of Record valid from 2019-04-24
Article History
First Online: 24 April 2019
Free to read: This content has been made available to all.